Medical Adventures @larryhbernsteinme - Tumblr Blog

RNA from the SARS-CoV-2 virus taking over the cells it infects: Virulence - Pathogen's ability to infect a Resistant Host: The Imbalance between Controlling virus Replication versus Activation of the Adaptive Immune Response

RNA from the SARS-CoV-2 virus taking over the cells it infects: Virulence – Pathogen’s ability to infect a Resistant Host: The Imbalance between Controlling virus Replication versus Activation of the Adaptive Immune Response

RNA from the SARS-CoV-2 virus taking over the cells it infects: Virulence – Pathogen’s ability to infect a Resistant Host: The Imbalance between Controlling Virus Replication versus Activation of the Adaptive Immune Response

Reporter: Aviva Lev-Ari, PhD, RN – I added colors and bold face

See

The Genome Structure of CORONAVIRUS, SARS-CoV-2

https://pharmaceuticalintelligence.com/2020/05/04/the-ge…

View On WordPress

Is Remdesivir the miracle cure or a short term cure for COVID-19?

Reporter: Irina Robu, PhD

In 1947, amid the “Golden Age” of antibiotic research that yielded many of the medicines used against bacteria such as chloramphenicol, a molecule that could combat a wide array of bacteria from different families. It was among the first FDA-approved broad-spectrum antibiotics used against…

View On WordPress

#broad spectrum antiviral drugs #Drug discovery #EIDD-2801 #remdesivir

Australian Children's Hospital: SARS-CoV-2 Testing

Australian Children’s Hospital: SARS-CoV-2 Testing

SARS-CoV-2 Testing and Outcomes in the First 30 Days After the First Case of COVID-19 at an Australian Children’s Hospital

Reporter: Gail S. Thornton, M.A.

2020

Objective: International studies describing COVID-19 in children have shown low proportions of paediatric cases and generally a mild clinical course. We aimed to present early data on children tested for SARS-CoV-2 at a large…

View On WordPress

#coronavirus #COVID-19 Treatment #Emergency department #hospital and patient #SARS-CoV-2

A Series of Recently Published Papers Report the Development of SARS-CoV2 Neutralizing Antibodies and Passive Immunity toward COVID19

Curator: Stephen J. Williams, Ph.D.

Passive Immunity and Treatment of Infectious Diseases

The ability of one person to pass on immunity to another person (passive immunity) is one of the chief methods we develop immunity to many antigens. For instance, maternal…

View On WordPress

#anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG)#coronavirus #COVID-19 #COVID-19 Treatment #humanized monoclonal antibody #neutralizing antibody #SARS-CoV-2

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership on May 18, 2020

The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Partnership on May 18, 2020: Leadership of AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Eli Lilly, Evotec, Gilead, GlaxoSmithKline, Johnson & Johnson, KSQ Therapeutics, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda, and Vir. We also thank multiple NIH institutes (especially NIAID), the FDA, BARDA, CDC, the…

View On WordPress

Race to develop antibody drugs for COVID-19

Reporter: Irina Robu, PhD

Even at the record pace vaccines are moving, the first vaccine for COVID-19 might not be available until next year. And even if it is available, it will take longer for enough people within the population to be vaccinated in order to achieve herd immunity and curb the spread. Companies such as Regeneron, Eli Lily, Amgen and Vir…

View On WordPress

#antiviral drugs #COVID-19 #immunity #Monoclonal antibodies #viral infections

Vaccinology in the Age of Pandemics: Strategies Against COVID-19 & Other Global Threats

June 15–16, 2020 | 11:00AM–3:30PM ET | 3:00–7:30PM UTC | 5:00–9:30PM CEST* *Program is subject to change

As the world faces the greatest global pandemic of our lifetimes, the critical importance of vaccine development has come to the forefront of scientific and public audiences alike. Over the course of…

View On WordPress

Bullet Item Summary - The COVID-19 Recovery will be digital: A plan for the First 90 Days

Bullet Item Summary – The COVID-19 Recovery will be digital: A plan for the First 90 Days

“McKinsey Digital” – 5/14/20

By Aamer Baig, Bryce Hall, Paul Jenkins, Eric Lamarre, and Brian McCarthy

1 – Most C-suite executives have led their companies to digitize some part of their business to protect employees and serve customers facing mobility restrictions.

2 – We have vaulted five years forward in consumer and business digital adoption in a matter of around eight weeks.

View On WordPress

Crowdsourcing Difficult-to-Collect Epidemiological Data in Pandemics: Lessons from Ebola to the current COVID-19 Pandemic

Curator: Stephen J. Williams, Ph.D.

At the onset of the COVID-19 pandemic, epidemiological data from the origin of the Sars-Cov2 outbreak, notably from the Wuhan region in China, was sparse. In fact, official individual patient data rarely become available early on in an…

View On WordPress

#China #coronavirus #Ebola virus #Epidemiology #Pandemic #Population Health Management #SARS-CoV-2

The Seasonality of COVID-19

Reporter: Irina Robu, PhD

There are several similarities between SARS-CoV-2 and SARS-CoV, because both viruses share a high degree of homology to SARS-like coronaviruses isolated from bats. The entire genome of SARS-CoV-2 has 86% similarity with SARS-CoV. COVID-19, SARS-CoV-2 has a higher transmissibility than SARS-CoV, where more patients with COVID-19 have mild…

View On WordPress

#ACE2 #COVID-19 #Infectious disease #Seasonality

Powerful Artificial Intelligence (AI) Tools Being Developed for the COVID-19 Fight

Powerful AI Tools Being Developed for the COVID-19 Fight

Curator: Stephen J. Williams, Ph.D.

Source: https://www.ibm.com/blogs/research/2020/04/ai-powered-technologies-accelerate-discovery-covid-19/

IBM Releases Novel AI-Powered Technologies to Help Health and Research Community Accelerate the Discovery of Medical Insights and Treatments for COVID-19

April 3, 2020 | Written by: Dario Gil

IBM…

View On WordPress

#COVID-19 #AI #Artificial intelligence #Artificial Intelligence & Clinical Trials #biotech innovation #DiA #IBM Watson #imaging #Pandemic #SARS-CoV-2 #Technion – Israel Institute of Technology

Expert moderators guiding discussions: 2020 World Medical Innovation Forum - COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights - MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Expert moderators guiding discussions: 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Dialogue among principals is a World Forum’s signature. Expert moderators guiding discussion and questions in audience friendly exchanges. No slides – shared perspectives facilitated by Harvard…

View On WordPress

Collaborative Innovation at 2020 World Medical Innovation Forum - COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights - MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Collaborative Innovation at 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Collaborative innovation has never been more important.

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Join top leaders guiding the response, technology and people confronting this century’s greatest health challenge.

View On WordPress

Thermo Fisher: Technologies required to return to work combating a COVID-19 resurgence at 2020 World Medical Innovation Forum - COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights - MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Thermo Fisher: Technologies required to return to work combating a COVID-19 resurgence at 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Thermo Fisher provides the technologies required to return to work as well as to combat a COVID-19 resurgence. CEO Marc Casper shares perspectives with MGB EVP Peter Markell.

View On WordPress

Life Science and Digital Health Investments - 2020 World Medical Innovation Forum - COVID-19, AI - MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Life Science and Digital Health Investments – 2020 World Medical Innovation Forum – COVID-19, AI – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

2020 World Medical Innovation Forum – COVID-19, AI – Life Science and Digital Health Investments, MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Life science and digital health investments have continued at a strong pace during the COVID-19 crisis. Senior investment leaders discuss what to expect. Will:

social distancing affect deal making?

key asset categories…

View On WordPress

Front line caregivers Nurses and other caregivers on COVID-19 patients and future of care at 2020 World Medical Innovation Forum - COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights - MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Front line caregivers Nurses and other caregivers on COVID-19 patients and future of care at 2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

Front line caregivers have combined passion and innovation throughout the crisis, saving lives and bringing lasting change across the care continuum.

Nurses and other caregivers will share how…

View On WordPress

The ”Disruptive Dozen” - Harnessing Technology to Reduce Health Disparities: Twelve mostly likely to have significant impact on healthcare by end of 2021.

The ”Disruptive Dozen” – Harnessing Technology to Reduce Health Disparities: Twelve mostly likely to have significant impact on healthcare by end of 2021.

2020 World Medical Innovation Forum – COVID-19, AI and the Future of Medicine, Featuring Harvard and Industry Leader Insights – MGH & BWH, Virtual Event: Monday, May 11, 8:15 a.m. – 5:15 p.m. ET

https://worldmedicalinnovation.org/2020-…

View On WordPress

Trending Blogs

Recently Viewed Blogs

Medical Adventures